| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |